translational-research

Documents about translational-research

• Ultra-high-sensitivity next-generation sequencing–based MRD predicts outcome in intensively treated older patients with acute myeloid leukemia: results from the ALFA-1200 cohort#250332HAL (France)
• OPtical Frequency Domain Imaging Versus INtravascular Ultrasound in Percutaneous Coronary InterventiON - OPINION Imaging#810138ClinicalTrials.gov
• International Prospective Observational Cohort Study for Optimal Bowel Resection Extent and Central Radicality for Colon Cancer#907563ClinicalTrials.gov
• Africa’s emerging role in precision oncology: translational insights from the harnessing functional genomics in cancer research conference, Windhoek, 23-26 September 2025#406899Springer Nature OA
• HCV and Co-morbid Alcohol Use Disorders: A Translational Investigation of Antiviral Therapy Outcomes on CNS Function#810082ClinicalTrials.gov
• Building Artificial Intelligence and Data Literacy Across the Health Care Research Workforce in the Mayo Clinic Center for Clinical and Translational Science: Why It Matters and What We Are Doing About It.#236102NCBI PubMed Central
• High-flow Nasal Cannula Therapy for Stable Chronic Obstructive Pulmonary Disease (COPD)#876501ClinicalTrials.gov
• PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer#995183ClinicalTrials.gov
• Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid#803613ClinicalTrials.gov
• The Need to Set up a Biobank Dedicated to Lymphoid Malignancies: Experience of a Single Center (Laboratory of Clinical and Experimental Pathology, University Côte d’Azur, Nice, France)#226851HAL (France)
• Functional Tests to Resolve Unsolved Rare Diseases. Rares.#914238ClinicalTrials.gov
• Evaluation of the Added Clinical Value of Donor-derived Cell-free DNA for the Monitoring of Cardiac Allograft Rejection.#867512ClinicalTrials.gov
• Erlotinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer#801048ClinicalTrials.gov
• Study of Erlotinib and Chemotherapy for Unresectable or Metastatic Cancer of the Esophagus and Gastric Cardia#979164ClinicalTrials.gov
• T Cells Promote Bronchial Epithelial Cell Secretion of Matrix Metalloproteinase-9 via a C-C Chemokine Receptor Type 2 Pathway: Implications for Chronic Lung Allograft Dysfunction#268703HAL (France)
• Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery#880634ClinicalTrials.gov
• International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases#905803ClinicalTrials.gov
• Wet and Dry Biomarkers to Predict Secondary Injury in Stroke: From Bench to Bedside - The NIMBLE Study#992996ClinicalTrials.gov
• Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer#871484ClinicalTrials.gov
• {'@classid': 'main title', '@classname': 'main title', '@schemeid': 'dnet:dataCite_title', '@schemename': 'dnet:dataCite_title', '@inferred': False, '@provenanceaction': 'sysimport:actionset', '@trust': '0.9', '$': '[Holistic integrative medicine: the road to the future of the development of burn medicine].'}#491149OpenAIRE
• Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies.#462147Repisalud
• Clues to maintaining calorie restriction? Psychosocial profiles of successful long-term restrictors☆ ☆ Acknowledgments: The authors gratefully recognize the extraordinary hard work of Trissa McClatchey, Wanda Truong, David Lowry, Jacob Miller, Becky Kim, Lydia Russell-Roy, and Alex Russell. Our deepest gratitude goes to all participants in this study, as well as grateful acknowledgement of the time, effort, and dedication they generously provided. The authors also wish to express special thanks to Paul McGlothin, President of the CR Way Longevity Center, and Meredith Averill, Executive Vice President of the CR Way Longevity Center, for their essential contribution to study recruitment and planning. This research was supported in part by a grant from the Robert Wood Johnson Foundation Health and Society Scholars Program, the UC Berkeley Population Center, the Appleby Health Foundation, and the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institu#983594eScholarship